Compare Deutsche Bank AG (DB) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deutsche Bank AG vs Inovio Pharmaceuticals Inc — how do they compare? Deutsche Bank AG trades at $38.31 (market cap $71.96B), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). The key difference: Deutsche Bank AG is far larger — about 916.1× Inovio Pharmaceuticals Inc's market cap, and Deutsche Bank AG pays a 3.04% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| DB | INO | |
|---|---|---|
Market Cap | $71.96B | $78.55M |
Sector | Financials | Health |
52-Week High | $40.33 | $2.87 |
52-Week Low | $28.37 | $0.66 |
Dividend Yield | 3.04% | — |
Enterprise Value | — | $49.56M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Deutsche Bank AG
In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.
Read more on DB →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
